Emergent BioSolutions EBS
NYSE EBS
$6.26 -0.10 (-1.49%)
As of: Oct 20, 2026 · 3:16 PM EDT

Emergent BioSolutions (EBS) Other Non-Current Liabilities (2010 - 2026)

Updated

Emergent BioSolutions' Other Non-Current Liabilities came in at $35.4 million for Q2 2026, down 10.4% from $39.5 million a year earlier and down 15.1% from the prior quarter.

Analysis

Emergent BioSolutions (EBS) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Emergent BioSolutions' Other Non-Current Liabilities was $53.9 million, up 37.9% from FY2024.

  • Other Non-Current Liabilities carries a five-year compound annual growth rate of -4.5% (FY2020 to FY2025).
  • Going back by year, Other Non-Current Liabilities was $39.1 million in FY2024 (+35.3%), $28.9 million in FY2023 (-30.4%), $41.5 million in FY2022 (-40.3%) and $69.5 million in FY2021 (+2.5%).
  • The five-year range for quarterly Other Non-Current Liabilities is $23.4 million (Q2 2023) to $69.5 million (Q4 2021).
  • Year-over-year, Other Non-Current Liabilities increased in seven of the last eight quarters, with growth averaging 24.3%.
  • The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q2 2025 (growth of 53.7%), and the weakest in Q2 2023 (a decline of 60.0%).
  • Business Quant data shows EBS's Other Non-Current Liabilities at $41.7 million (Q1 2026), $53.9 million (Q4 2025) and $42.6 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,147.42 Bn 1,116.01 Bn 19.71 Bn
2 Johnson & Johnson 623.36 Bn 541.89 Bn 17.26 Bn
3 AbbVie 509.56 Bn 482.67 Bn 12.70 Bn
4 Merck 365.93 Bn 320.31 Bn 12.21 Bn
5 Novartis Ag 297.31 Bn 261.30 Bn 11.24 Bn
6 Astrazeneca 261.52 Bn 235.20 Bn 12.86 Bn
7 Amgen 235.01 Bn 190.41 Bn 7.24 Bn
8 Gilead Sciences 193.77 Bn 167.97 Bn 6.22 Bn
9 Pfizer 171.91 Bn 118.56 Bn 10.94 Bn
10 Emergent BioSolutions 323.02 Mn -427.88 Mn 137.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 35.40 Mn
Mar 31, 2026 41.70 Mn
Dec 31, 2025 53.90 Mn
Sep 30, 2025 42.60 Mn
Jun 30, 2025 39.50 Mn
Mar 31, 2025 35.40 Mn
Dec 31, 2024 39.10 Mn
Sep 30, 2024 35.80 Mn
Jun 30, 2024 25.70 Mn
Mar 31, 2024 28.00 Mn
Dec 31, 2023 28.90 Mn
Sep 30, 2023 31.30 Mn
Jun 30, 2023 23.40 Mn
Mar 31, 2023 24.10 Mn
Dec 31, 2022 41.50 Mn
Sep 30, 2022 52.30 Mn
Jun 30, 2022 58.50 Mn
Mar 31, 2022 61.30 Mn
Dec 31, 2021 69.50 Mn
Sep 30, 2021 101.50 Mn
API Access

Emergent BioSolutions Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=EBS&period=max&api_key=YOUR_API_KEY